Genfit Stock

Genfit EBITDA per Employee

The EBITDA per Employee of Genfit (GNFT.PA) as of Aug 9, 2026 is 28,360.00 EUR. In the previous year, EBITDA per Employee was -143,080.00 EUR — a change of -119.82% (higher).

EBITDA per Employee

28,360.00EUR

YoY

-119.82%

Last updated:

EBITDA per Employee of Genfit is 2026 28,360.00 EUR. EBITDA per Employee of Genfit was 2025 -143,080.00 EUR. It decreases by -119.82% higher compared to the previous year.
Access this data via the Eulerpool API

Genfit Stock analysis

What does Genfit do? Genfit SA is a French company specializing in the development of therapies for the treatment of liver diseases, specifically non-alcoholic steatohepatitis (NASH). The company was founded in 1999 and is headquartered in Loos, France. Genfit is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Genfit stock

EBITDA per Employee of Genfit is 28,360.00 EUR in 2026.

EBITDA per Employee of Genfit changed from -143,080.00 EUR to 28,360.00 EUR, representing a -119.82% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Employee Genfit since 2006 – with annual values, charts, and detailed analysis.

EBITDA per employee measures operating cash earnings generated per employee, showing workforce productivity before depreciation and financing effects.

EBITDA per Employee's EUR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA per Employee's Genfit historically and in real time.

Access this data via the Eulerpool API

Workforce — Genfit

All Key Metrics — Genfit